http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-209226996-U
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_98756967ba023244c6ef96e9cd38b58d |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12M1-40 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K1-34 |
| filingDate | 2018-11-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2019-08-09-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_cc9ae77df196242b7e9b00ba504207c4 |
| publicationDate | 2019-08-09-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CN-209226996-U |
| titleOfInvention | A kind of capsular polysaccharide vaccine protein nucleic acid removal device |
| abstract | The utility model discloses a kind of capsular polysaccharide vaccine protein nucleic acid removal devices, including the nucleic acid enzyme reactor, Proteinase K reactor and hollow fiber column being serially connected, four mouthfuls of valves of feed liquor two-way are connected at the top of the nucleic acid enzyme reactor, the filler import communicated with inner cavity is installed on the side wall of nucleic acid enzyme reactor, the bottom of the Proteinase K reactor is connected with four mouthfuls of valves of tapping two-way, is equipped on the side wall of Proteinase K reactor and communicates Proteinase K filler import with inner cavity.The pod membrane raw sugar of this capsular polysaccharide vaccine protein nucleic acid removal device, preliminary purification is digested to small oligonucleotides；Series connection enters Proteinase K reactor, and it is small molecule amino acid that Proteinase K, which decomposes digestion, is digested to amino acid polypeptide segment；While capsular polysaccharide macromolecular is concentrated by ultrafiltration, small molecule amino acid, oligonucleotide fragment are resolved into, separates and is discharged, solves nuclease/Proteinase K residual, the problem of polysaccharide vaccine concentration and nucleic acid, Protein Separation. |
| priorityDate | 2018-11-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 19.